Dept of Physiology and Pharmacology, Center for Cardiovascular and Respiratory Sciences, West Virginia Univ., Morgantown, WV 26506, USA.
Am J Physiol Regul Integr Comp Physiol. 2012 Nov 15;303(10):R1003-10. doi: 10.1152/ajpregu.00335.2012. Epub 2012 Sep 26.
Previously, we have shown that A(2A) adenosine receptor (A(2A)AR) mediates aortic relaxation via cytochrome P-450 (CYP)-epoxygenases. However, the signaling mechanism is not understood properly. We hypothesized that ATP-sensitive K(+) (K(ATP)) channels play an important role in A(2A)AR-mediated relaxation. Organ bath and Western blot experiments were done using isolated aorta from A(2A)KO and corresponding wild-type (WT) mice. Aortic rings from WT and A(2A) knockout (KO) mice were precontracted with submaximal dose of phenylephrine (PE, 10(-6) M), and concentration-response curves for pinacidil, cromakalim (nonselective K(ATP) openers), and diazoxide (mitochondrial K(ATP) opener) were obtained. Diazoxide did not have any relaxation effect on PE-precontracted tissues, whereas relaxation to pinacidil (48.09 ± 5.23% in WT vs. 25.41 ± 2.73% in A(2A)KO; P < 0.05) and cromakalim (51.19 ± 2.05% in WT vs. 38.50 ± 2.26% in A(2A)KO; P < 0.05) was higher in WT than A(2A)KO aorta. This suggested the involvement of sarcolemmal rather than mitochondrial K(ATP) channels. Endothelium removal, treatment with SCH 58651 (A(2A)AR antagonist; 10(-6) M), N(G)-nitro-l-arginine methyl ester (l-NAME, nitric oxide synthase inhibitor) and methylsulfonyl-propargyloxyphenylhexanamide (MS-PPOH, CYP-epoxygenases inhibitor; 10(-5) M) significantly reduced pinacidil-induced relaxation in WT compared with controls, whereas these treatments did not have any effect in A(2A)KO aorta. Glibenclamide (K(ATP) channel inhibitor, 10(-5) M) blocked 2-p-(2-carboxyethyl)phenethylamino-5'N-ethylcarboxamido adenosine hydrochloride (CGS 21680, A(2A)AR agonist)-induced relaxation in WT and changed 5'-N-ethylcarboxamide (NECA) (nonselective adenosine analog)-induced response to higher contraction in WT and A(2A)KO. 5-Hydroxydecanoate (5-HD, mitochondrial K(ATP) channel inhibitor, 10(-4) M) had no effect on CGS 21680-mediated response in WT aorta. Our data suggest that A(2A)AR-mediated vasorelaxation occurs through opening of sarcolemmal K(ATP) channels via CYP-epoxygenases and possibly, nitric oxide, contributing to pinacidil-induced responses.
先前,我们已经证实 A(2A) 腺苷受体 (A(2A)AR) 通过细胞色素 P-450 (CYP)-环氧合酶介导主动脉舒张。然而,其信号机制尚未得到很好的理解。我们假设三磷酸腺苷敏感性钾 (K(ATP)) 通道在 A(2A)AR 介导的舒张中发挥重要作用。使用来自 A(2A)KO 和相应野生型 (WT) 小鼠的离体主动脉进行器官浴和 Western blot 实验。用苯肾上腺素 (PE,10(-6) M) 将 WT 和 A(2A) 敲除 (KO) 小鼠的主动脉环预收缩,获得匹那地尔、克罗卡林 (非选择性 K(ATP) 开放剂) 和 diazoxide (线粒体 K(ATP) 开放剂) 的浓度反应曲线。Diazoxide 对 PE 预收缩组织没有任何舒张作用,而匹那地尔 (WT 组为 48.09 ± 5.23%,A(2A)KO 组为 25.41 ± 2.73%;P < 0.05) 和克罗卡林 (WT 组为 51.19 ± 2.05%,A(2A)KO 组为 38.50 ± 2.26%;P < 0.05) 的舒张作用在 WT 比 A(2A)KO 主动脉中更高。这表明涉及肌浆网而不是线粒体 K(ATP) 通道。内皮细胞去除、SCH 58651 (A(2A)AR 拮抗剂;10(-6) M)、N(G)-硝基-L-精氨酸甲酯 (l-NAME,一氧化氮合酶抑制剂) 和甲基磺酰基丙炔氧苯己酰胺 (MS-PPOH,CYP-环氧合酶抑制剂;10(-5) M) 处理显著降低 WT 中匹那地尔诱导的舒张与对照组相比,而这些处理对 A(2A)KO 主动脉没有任何影响。格列本脲 (K(ATP) 通道抑制剂,10(-5) M) 阻断 2-p-(2-羧乙基)苯乙胺-5'-N-乙基羧酰胺基腺苷盐酸盐 (CGS 21680,A(2A)AR 激动剂) 诱导的 WT 和改变 5'-N-乙基羧酰胺 (NECA)(非选择性腺苷类似物)诱导的反应,导致 WT 和 A(2A)KO 中的更高收缩。5-羟基癸酸 (5-HD,线粒体 K(ATP) 通道抑制剂,10(-4) M) 对 WT 主动脉中 CGS 21680 介导的反应没有影响。我们的数据表明,A(2A)AR 介导的血管舒张通过 CYP-环氧合酶诱导的肌浆网 K(ATP) 通道开放和可能的一氧化氮来实现,这有助于匹那地尔诱导的反应。